Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (canada) - norethisterone; ethinylestradiol - oral tablet - 500microgram ; 35microgram

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported - norethisterone; ethinylestradiol - oral tablet - 500microgram ; 35microgram

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported - norethisterone; ethinylestradiol - oral tablet - 1mg ; 35microgram

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported - norethisterone; mestranol - oral tablet - 1mg ; 50microgram

Indja - Ingliż - Central Drugs Standard Control Organization

atoz ph. - norethisterone - tab - 5mg - 10

Kenja - Ingliż - Pharmacy and Poisons Board

questa care inc. c/o surgilinks ltd p.o. box 5124 madonna road san luis obispo ca - norethisterone tablets bp - tablet - norethisterone bp 5mg - hormonal contraceptives: progestogens for

Kenja - Ingliż - Pharmacy and Poisons Board

ray pharmaceuticals ltd p.o. box 22830-00400 nairobi - norethisterone - tablet - norethisterone 5mg - hormonal contraceptives: progestogens for

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - norethisterone acetate; oestradiol hemihydrate; oestradiol -

Unjoni Ewropea - Ingliż - EMA (European Medicines Agency)

gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyoma - pituitary and hypothalamic hormones and analogues - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

gedeon richter australia pty ltd - relugolix, quantity: 40 mg; estradiol, quantity: 1 mg (equivalent: estradiol hemihydrate, qty 1.032 mg); norethisterone acetate, quantity: 0.5 mg - tablet, film coated - excipient ingredients: mannitol; sodium starch glycollate type a; magnesium stearate; lactose monohydrate; hyprolose; titanium dioxide; hypromellose; triacetin; iron oxide yellow - ryeqo is indicated in adult women of reproductive age for:,? treatment of moderate to severe symptoms of uterine fibroids,,?symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis (see section 5.1 pharmacodynamic properties).